Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
Lee Equity Partners
Growth
58 people
US Venture Partners
Menlo ParkSeed–Late Stage$500K – $10M
12 people
Vivo Capital
Palo AltoSeed–Late Stage$10M – $50M
25 people
LIFTT
TorinoPre-Seed–Late Stage
35 people
Advent International
BostonSeries A–Late Stage$1.1B
47 people
Amadeus Capital Partners
LondonPre-Seed–Late Stage$50K – $12.7M
34 people
Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
42 people
Palatine
ManchesterSeries B–Growth
42 people
W Capital Partners
New YorkGrowth–Late Stage
21 people
FTV Capital
New YorkSeries A–Growth$10M – $30M
13 people
BlackRock
WilmingtonSeries A–Growth
57 people
Sandbox Industries
ChicagoSeed–Growth
46 people
Capricorn Venture Partners
LeuvenSeed–Late Stage$270K – $10.8M
30 people
Breyer Capital
AustinPre-Seed–Growth$500K – $10M
10 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
Endeavour Capital
PortlandGrowth–Late Stage$35M – $100M
29 people
Taiwania Capital
TaipeiSeed–Growth$3M – $85M
43 people
.406 Ventures
BostonSeed–Growth$1M – $4M
17 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
Japan Social Innovation and Investment Foundation
Pre-Seed–Growth
53 people
BIP Ventures
AtlantaPre-Seed–Late Stage
19 people
Eclipse Ventures
Palo AltoPre-Seed–Late Stage$200K – $5M
37 people
Icehouse Ventures
AucklandPre-Seed–Late Stage$120K – $2.4M
30 people
NTT DOCOMO Ventures
TokyoSeed–Growth
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.


















































































